医学
抗血栓
经皮冠状动脉介入治疗
心房颤动
传统PCI
心脏病学
内科学
急性冠脉综合征
冠状动脉疾病
心肌梗塞
作者
Renato D. Lópes,Hwanhee Hong,Ralf E. Harskamp,Deepak L. Bhatt,Roxana Mehran,Christopher P. Cannon,Christopher B. Granger,Freek W.A. Verheugt,Jianghao Li,Jurriën M. ten Berg,Nikolaus Sarafoff,C. Michael Gibson,John H. Alexander
出处
期刊:JAMA Cardiology
[American Medical Association]
日期:2019-06-19
卷期号:4 (8): 747-747
被引量:223
标识
DOI:10.1001/jamacardio.2019.1880
摘要
The antithrombotic treatment of patients with atrial fibrillation (AF) and coronary artery disease, in particular with acute coronary syndrome (ACS) and/or percutaneous coronary intervention (PCI), poses a significant treatment dilemma in clinical practice.
科研通智能强力驱动
Strongly Powered by AbleSci AI